European Registry on Helicobacter pylori management (Hp-EuReg) patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients /
The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care.International multicentre prospective non-interventional registry starting in 2013 aimed to evaluate the decisions and outcomes in H....
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2021
|
| Sorozat: | GUT
70 No. 1 |
| Tárgyszavak: | |
| doi: | 10.1136/gutjnl-2020-321372 |
| mtmt: | 32159142 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/22165 |
| LEADER | 03182nab a2200385 i 4500 | ||
|---|---|---|---|
| 001 | publ22165 | ||
| 005 | 20211013134605.0 | ||
| 008 | 210830s2021 hu o 0|| zxx d | ||
| 022 | |a 0017-5749 | ||
| 024 | 7 | |a 10.1136/gutjnl-2020-321372 |2 doi | |
| 024 | 7 | |a 32159142 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Nyssen Olga P | |
| 245 | 1 | 0 | |a European Registry on Helicobacter pylori management (Hp-EuReg) |h [elektronikus dokumentum] : |b patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients / |c Nyssen Olga P |
| 260 | |c 2021 | ||
| 300 | |a 40-54 | ||
| 490 | 0 | |a GUT |v 70 No. 1 | |
| 520 | 3 | |a The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care.International multicentre prospective non-interventional registry starting in 2013 aimed to evaluate the decisions and outcomes in H. pylori management by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap. Variables included demographics, previous eradication attempts, prescribed treatment, adverse events and outcomes. Data monitoring was performed to ensure data quality. Time-trend and geographical analyses were performed.30 394 patients from 27 European countries were evaluated and 21 533 (78%) first-line empirical H. pylori treatments were included for analysis. Pretreatment resistance rates were 23% to clarithromycin, 32% to metronidazole and 13% to both. Triple therapy with amoxicillin and clarithromycin was most commonly prescribed (39%), achieving 81.5% modified intention-to-treat eradication rate. Over 90% eradication was obtained only with 10-day bismuth quadruple or 14-day concomitant treatments. Longer treatment duration, higher acid inhibition and compliance were associated with higher eradication rates. Time-trend analysis showed a region-dependent shift in prescriptions including abandoning triple therapies, using higher acid-inhibition and longer treatments, which was associated with an overall effectiveness increase (84%-90%).Management of H. pylori infection by European gastroenterologists is heterogeneous, suboptimal and discrepant with current recommendations. Only quadruple therapies lasting at least 10 days are able to achieve over 90% eradication rates. European recommendations are being slowly and heterogeneously incorporated into routine clinical practice, which was associated with a corresponding increase in effectiveness. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Bordin Dmitry |e aut |
| 700 | 0 | 1 | |a Tepes Bojan |e aut |
| 700 | 0 | 2 | |a Pérez-Aisa Ángeles |e aut |
| 700 | 0 | 2 | |a Vaira Dino |e aut |
| 700 | 0 | 2 | |a Caldas Maria |e aut |
| 700 | 0 | 2 | |a Bujanda Luis |e aut |
| 700 | 0 | 2 | |a Castro-Fernandez Manuel |e aut |
| 700 | 0 | 2 | |a Lerang Frode |e aut |
| 700 | 0 | 2 | |a Leja Marcis |e aut |
| 700 | 0 | 2 | |a Rodrigo Luís |e aut |
| 700 | 0 | 2 | |a Rokkas Theodore |e aut |
| 700 | 0 | 2 | |a Kupcinskas Limas |e aut |
| 700 | 0 | 2 | |a Pérez-Lasala Jorge |e aut |
| 700 | 0 | 2 | |a Czakó László |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/22165/1/NyssenGut2021.pdf |z Dokumentum-elérés |